Evidence map›Paper›PMID 32305206›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2020

CKD Awareness Among US Adults by Future Risk of Kidney Failure.

Chi D Chu, Charles E McCulloch, Tanushree Banerjee, Meda E Pavkov, Nilka R Burrows, Brenda W Gillespie, Rajiv Saran, Michael G Shlipak, Neil R Powe, Delphine S Tuot and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 124 citations in OpenAlex.

  1. ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome.Journal of the American Society of Nephrology : JASN · 2026
    Guideline
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Chi D ChuDepartments of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: chi.chu@ucsf.edu.
Charles E McCullochBiostatistics and Epidemiology, University of California San Francisco, San Francisco, CA.
Tanushree BanerjeeDepartments of Medicine, University of California San Francisco, San Francisco, CA.
Meda E PavkovDivision of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA.
Nilka R BurrowsDivision of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA.
Brenda W GillespieKidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, MI.
Rajiv SaranKidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, MI; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI.
Michael G ShlipakKidney Health Research Collaborative, San Francisco Veterans Affairs Hospital, San Francisco, CA.
Neil R PoweDepartments of Medicine, University of California San Francisco, San Francisco, CA; Department of Medicine, Priscilla Chan and Mark Zuckerberg San Francisco General Hospital, San Francisco, CA.
Delphine S TuotDepartments of Medicine, University of California San Francisco, San Francisco, CA; Department of Medicine, Priscilla Chan and Mark Zuckerberg San Francisco General Hospital, San Francisco, CA.
Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team
University of California, San Francisco · USCenters for Disease Control and Prevention · USSan Francisco General Hospital · USSan Francisco VA Medical Center · USUniversity of Michigan · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Evaluating the Impact of Guidelines on Physician Prescription Practices in Chronic Kidney DiseaseF32DK122629 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHU, CHI · 2019 to 2020
$157k
CDC HHS U58 DP006254NIDDK NIH HHS F32 DK122629NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK092926
6 · The paper itself

Abstract

RATIONALE &

objectivePersons with chronic kidney disease (CKD) are often unaware of their disease status. Efforts to improve CKD awareness may be most effective if focused on persons at highest risk for progression to kidney failure. STUDY

designSerial cross-sectional surveys. SETTING &

participantsNonpregnant adults (aged≥20 years) with CKD glomerular filtration rate categories 3-4 (G3-G4) who participated in the National Health and Nutrition Examination Survey from 1999 to 2016 (n = 3,713). PREDICTOR: 5-year kidney failure risk, estimated using the Kidney Failure Risk Equation. Predicted risk was categorized as minimal (<2%), low (2%-<5%), intermediate (5%-<15%), or high (≥15%). OUTCOME: CKD awareness, defined by answering "yes" to the question "Have you ever been told by a doctor or other health professional that you had weak or failing kidneys?" ANALYTICAL APPROACH: Prevalence of CKD awareness was estimated within each risk group using complex sample survey methods. Associations between Kidney Failure Risk Equation risk and CKD awareness were assessed using multivariable logistic regression. CKD awareness was compared with awareness of hypertension and diabetes during the same period.

resultsIn 2011 to 2016, unadjusted CKD awareness was 9.6%, 22.6%, 44.7%, and 49.0% in the minimal-, low-, intermediate-, and high-risk groups, respectively. In adjusted analyses, these proportions did not change over time. Awareness of CKD, including among the highest risk group, remains consistently below that of hypertension and diabetes and awareness of these conditions increased over time. LIMITATIONS: Imperfect sensitivity of the "weak or failing kidneys" question for ascertaining CKD awareness.

conclusionsAmong adults with CKD G3-G4 who have 5-year estimated risks for kidney failure of 5%-<15% and≥15%, approximately half were unaware of their kidney disease, a gap that has persisted nearly 2 decades.

Indexed as

AwarenessGlomerular Filtration RateAgedDisclosureDisease ProgressionFemaleHealth Knowledge, Attitudes, PracticeHumansKidney Failure, ChronicMaleMiddle AgedNutrition SurveysRenal Insufficiency, ChronicRisk AssessmentSeverity of Illness IndexUnited StatesalbuminuriaChronic kidney disease (CKD)CKD awarenessdisease managementestimated glomerular filtration rate (eGFR)health literacykidney failure preventionnationally representative surveypatient empowermentpublic healthrenal functionrenal insufficiencyself-careurinary albumin-creatinine ratio (UACR)

Identifiers

PMID32305206
PMCPMC7387135
OpenAlexW3017195190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.